Hangzhou Tigermed Consulting Co., Ltd (HKG:3347)

HKG:3347 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	6,432	6,474	7,289	7,002	5,187	3,176
Other Revenue	129.04	129.04	94.93	83.93	26.17	16.04
Revenue	6,561	6,603	7,384	7,085	5,214	3,192
Revenue Growth (YoY)	-3.53%	-10.58%	4.21%	35.91%	63.32%	13.88%
Cost of Revenue	4,822	4,359	4,539	4,277	2,943	1,678
Gross Profit	1,740	2,244	2,845	2,808	2,271	1,514
Selling, General & Admin	947.38	944.45	837.52	780.02	676.88	487.22
Research & Development	257.53	238.39	261.56	234.62	211.83	156.65
Other Operating Expenses	20.66	22.2	19.15	7.17	12.5	3.67
Operating Expenses	1,238	1,235	1,155	1,046	926.93	635.57
Operating Income	501.81	1,009	1,690	1,763	1,344	878.67
Interest Expense	-186.02	-141.24	-119.9	-83.18	-24.91	-50.78
Interest & Investment Income	587.92	256.86	568.02	330.09	568.16	394.16
Currency Exchange Gain (Loss)	18.02	18.02	2.61	20.13	-11.83	-147.08
Other Non Operating Income (Expenses)	-14.89	-6.59	-3.32	-6.88	-1.48	-2.48
EBT Excluding Unusual Items	906.84	1,137	2,138	2,023	1,874	1,073
Impairment of Goodwill	-5	-5	-29.16	-	-	-
Gain (Loss) on Sale of Investments	-144.08	-501.69	352.77	535.86	1,815	1,138
Gain (Loss) on Sale of Assets	6.11	3.56	-0.19	-0.09	-0.53	-0.89
Asset Writedown	5.26	-	-	-0.45	-	-
Other Unusual Items	31.05	31.05	27.24	27.1	-3.96	9.2
Pretax Income	800.18	664.46	2,489	2,585	3,685	2,219
Income Tax Expense	163.8	216.63	338.61	313.65	292.86	189.71
Earnings From Continuing Operations	636.38	447.83	2,150	2,272	3,392	2,029
Minority Interest in Earnings	-24.23	-42.69	-125.08	-265.17	-517.54	-279.23
Net Income	612.15	405.14	2,025	2,007	2,874	1,750
Net Income to Common	612.15	405.14	2,025	2,007	2,874	1,750
Net Income Growth	-36.15%	-79.99%	0.91%	-30.19%	64.26%	107.90%
Shares Outstanding (Basic)	857	863	865	865	868	795
Shares Outstanding (Diluted)	857	863	865	866	871	799
Shares Change (YoY)	-0.83%	-0.22%	-0.07%	-0.62%	9.01%	7.27%
EPS (Basic)	0.71	0.47	2.34	2.32	3.31	2.20
EPS (Diluted)	0.71	0.47	2.34	2.32	3.30	2.19
EPS Growth	-35.55%	-79.94%	0.86%	-29.70%	50.69%	93.81%
Free Cash Flow	1,006	740.45	836.68	908.9	1,055	842.18
Free Cash Flow Per Share	1.17	0.86	0.97	1.05	1.21	1.05
Dividend Per Share	0.300	0.300	0.568	0.550	0.500	0.300
Dividend Growth	-47.18%	-47.18%	3.27%	10.00%	66.67%	7.91%
Gross Margin	26.51%	33.99%	38.53%	39.64%	43.55%	47.44%
Operating Margin	7.65%	15.29%	22.89%	24.88%	25.77%	27.52%
Profit Margin	9.33%	6.14%	27.42%	28.32%	55.13%	54.81%
Free Cash Flow Margin	15.33%	11.21%	11.33%	12.83%	20.24%	26.38%
EBITDA	722.16	1,215	1,876	1,921	1,458	958.59
EBITDA Margin	11.01%	18.40%	25.40%	27.12%	27.97%	30.03%
D&A For EBITDA	220.34	205.22	185.06	158.69	114.71	79.92
EBIT	501.81	1,009	1,690	1,763	1,344	878.67
EBIT Margin	7.65%	15.29%	22.89%	24.88%	25.77%	27.52%
Effective Tax Rate	20.47%	32.60%	13.61%	12.13%	7.95%	8.55%
Revenue as Reported	6,561	6,603	7,384	7,085	5,214	3,192
Advertising Expenses	-	14.1	19.97	19.24	14.45	10.98

Source: S&P Global Market Intelligence. Standard template. Financial Sources.